Portugal Pharmaceuticals & Healthcare Q1 2021
Key View:
New rules aimed at reducing medicine shortages will increase the burden on pharmaceutical firms to monitor stocklevels and to ensure the supply of medicines in the Portuguese market, thereby limiting their ability to capitalise on price variationsacross the EU. Portugal’s pharmaceutical market will grow over the forecast period, although a repressive pricing environment andweak reimbursement profile will limit its attractiveness when compared to its peers in Western Europe. While public health spendingwill increase over the next few years, private health spending will continue to increase as a share of total health expenditure, asinvestment in public sector facilities remains below demand trends. The growing Portugal-based cannabis medicine industry willdrive investment opportunities.
- Key View
- Portugal Pharmaceuticals & Healthcare Covid-19 Impact
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Industry Risk/Reward Index
- Western Europe Innovative Pharmaceuticals Risk/Reward Index
- Innovative Pharmaceuticals Risk/Reward Index
- Regulatory Development
- Regulatory Review
- Market Overview
- Competitive Landscape
- Company Profile
- Bial
- Bluepharma
- Hovione
- Medinfar
- Portugal Demographic Outlook
- Pharmaceuticals & Healthcare Glossary
- Pharmaceuticals & Healthcare Methodology
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook